[1]
|
Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533.
https://doi.org/10.1038/s41586-021-03392-8
|
[2]
|
Sharpe, A.H. and Pauken, K.E. (2018) The Diverse Functions of the PD1 Inhibitory Pathway. Nature Reviews Immunology, 18, 153-167. https://doi.org/10.1038/nri.2017.108
|
[3]
|
Han, Y., et al. (2018) Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy. Frontiers in Immunology, 9, 1774. https://doi.org/10.3389/fimmu.2018.01774
|
[4]
|
Wolf, D. and Ley, K. (2019) Immunity and Inflammation in Ath-erosclerosis. Circulation Research, 124, 315-327.
https://doi.org/10.1161/CIRCRESAHA.118.313591
|
[5]
|
Wiktorin, G., et al. (2019) Histamine Targets Mye-loid-Derived Suppressor Cells and Improves the Anti-Tumor Efficacy of PD-1/PD-L1 Checkpoint Blockade. Cancer Immunology, Immunotherapy: CII, 68, 163-174.
https://doi.org/10.1007/s00262-018-2253-6
|
[6]
|
Van Damme, H., Dombrecht, B., Kiss, M., et al. (2021) Thera-peutic Depletion of CCR8+ Tumor-Infiltrating Regulatory T Cells Elicits Antitumor Immunity and Synergizes with An-ti-PD-1 Therapy. Journal for Immunotherapy of Cancer, 9, e001749. https://doi.org/10.1136/jitc-2020-001749
|
[7]
|
Wang, Y., Liu, S., Yang, Z., et al. (2021) Anti-PD-1/L1 Lead-In be-fore MAPK Inhibitor Combination Maximizes Antitumor Immunity and Efficacy. Cancer Cell, 39, 1375-1387.e6. https://doi.org/10.1016/j.ccell.2021.07.023
|
[8]
|
Kiyokawa, J., Kawamura, Y., Ghouse, S.M., et al. (2021) Modifi-cation of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma. Clinical Cancer Research, 27, 889-902.
https://doi.org/10.1158/1078-0432.CCR-20-2400
|
[9]
|
Marchio, P., Guerra-Ojeda, S., Vila, J.M., et al. (2019) Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Lon-gevity, 2019, Article ID: 8563845.
https://doi.org/10.1155/2019/8563845
|
[10]
|
Khatana, C., Saini, N.K., Chakrabarti, S., et al. (2020) Mechanistic In-sights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 5245308.
https://doi.org/10.1155/2020/5245308
|
[11]
|
Wang, Y., Gao, D., Jin, L., et al. (2022) NADPH Selective Depletion Nanomedicine-Mediated Radio-Immunometabolism Regulation for Strengthening Anti-PDL1 Therapy against TNBC. Advanced Science (Weinh). e2203788.
https://doi.org/10.1002/advs.202203788
|
[12]
|
Wang, W., Chapman, N.M., Zhang, B., et al. (2019) Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression. Cancer Research, 79, 2909-2922.
https://doi.org/10.1158/0008-5472.CAN-18-3134
|
[13]
|
Yu, Y.R., Imrichova, H., Wang, H., et al. (2020) Disturbed Mitochondrial Dynamics in CD8+ TILs Reinforce T Cell Exhaustion. Nature Immunology, 21, 1540-1551. https://doi.org/10.1038/s41590-020-0793-3
|
[14]
|
Jiménez-Fernández, M., Rodríguez-Sinovas, C., Cañes, L., et al. (2022) CD69-oxLDL Ligand Engagement Induces Programmed Cell Death 1 (PD-1) Expression in Human CD4 + T Lymphocytes. Cellular and Molecular Life Sciences, 79, 468. https://doi.org/10.1007/s00018-022-04481-1
|
[15]
|
Park, J.H., Kang, Y.J., et al. (2016) Microfluidics for Simulta-neous Quantification of Platelet Adhesion and Blood Viscosity. Scientific Reports, 6, Article No. 24994. https://doi.org/10.1038/srep24994
|
[16]
|
Ramasamy, I. (2004) Inherited Bleeding Disorders: Disorders of Platelet Adhesion and Aggregation. Critical Reviews in Oncology/Hematology, 49, 1-35. https://doi.org/10.1016/S1040-8428(03)00117-3
|
[17]
|
Dharmapuri, S., Özbek, U., Lin, J.Y., et al. (2020) Predictive Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Advanced Hepatocellular Carcinoma Pa-tients Treated with Anti-PD-1 Therapy. Cancer Medicine, 9, 4962-4970. https://doi.org/10.1002/cam4.3135
|
[18]
|
Miyata, J., Fukunaga, K., Iwamoto, R., et al. (2013) Dysregulated Synthe-sis of Protectin D1 in Eosinophils from Patients with Severe Asthma. Journal of Allergy and Clinical Immunology, 131, 353-360.e602.
https://doi.org/10.1016/j.jaci.2012.07.048
|
[19]
|
Vibhakar, R., Juan, G., Traganos, F., Darzynkiewicz, Z. and Finger, L.R. (1997) Activation-Induced Expression of Human Programmed Death-1 Gene in T-Lymphocytes. Experimental Cell Research, 232, 25-28.
https://doi.org/10.1006/excr.1997.3493
|
[20]
|
Poznyak, A., Grechko, A.V., Poggio, P., et al. (2020) The Diabetes Mellitus—Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Interna-tional Journal of Molecular Sciences, 21, 1835.
https://doi.org/10.3390/ijms21051835
|
[21]
|
Patsoukis, N. (2015) PD-1 Alters T-Cell Metabolic Reprogramming by Inhibiting Glycolysis and Promoting Lipolysis and Fatty Acid Oxidation. Nature Communications, 6, 6692. https://doi.org/10.1038/ncomms7692
|
[22]
|
He, F., et al. (2021) Mitophagy-Mediated Adipose Inflammation Con-tributes to Type 2 Diabetes with Hepatic Insulin Resistance. The Journal of Experimental Medicine, 218, e20201416. https://doi.org/10.1084/jem.20201416
|
[23]
|
Marette, A., Liu, Y. and Sweeney, G. (2014) Skeletal Muscle Glucose Metabolism and Inflammation in the Development of the Metabolic Syndrome. Reviews in Endocrine and Metabolic Disorders, 15, 299-305.
https://doi.org/10.1007/s11154-014-9296-6
|
[24]
|
Thomas-Wohlever, J. and Lee, I. (2002) Kinetic Characterization of the Peptidase Activity of Escherichia coli Lon Reveals the Mechanistic Similarities in ATP-Dependent Hydrolysis of Peptide and Protein Substrates. Biochemistry, 41, 9418-9425. https://doi.org/10.1021/bi0255470
|
[25]
|
Dent, P., Booth, L., Roberts, J.L., Poklepovic, A. and Hancock, J.F. (2020) (Curcumin+Sildenafil) Enhances the Efficacy of 5FU and Anti-PD1 Therapies in Vivo. Journal of Cellular Physiology, 235, 6862-6874.
https://doi.org/10.1002/jcp.29580
|
[26]
|
Shayan, G., Srivastava, R., Li, J., Schmitt, N., Kane, L.P. Ferris, R.L. (2016) Adaptive Resistance to Anti-PD1 Therapy by Tim-3 Upregulation Is Mediated by the PI3K-Akt Pathway in Head and Neck Cancer. Oncoimmunology, 6, e1261779.
https://doi.org/10.1080/2162402X.2016.1261779
|
[27]
|
Sundarraj, K., Raghunath, A., Panneerselvam, L. and Pe-rumal, E. (2021) Fisetin Inhibits Autophagy in HepG2 Cells via PI3K/Akt/mTOR and AMPK Pathway. Nutrition and Cancer, 73, 2502-2514.
https://doi.org/10.1080/01635581.2020.1836241
|
[28]
|
Zou, Y., Gan, C.L., Xin, Z., et al. (2021) Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models. Frontiers in Cell and Developmental Biology, 9, Article ID: 769229. https://doi.org/10.3389/fcell.2021.769229
|
[29]
|
杨思琪, 王健, 童兰, 齐灵垚, 陈旭, 蔡琳. 血管平滑肌细胞凋亡对动脉粥样硬化作用的研究进展[J]. 中南大学学报(医学版), 2021, 46(8): 872-876.
|
[30]
|
王梦楠, 秦合伟, 郭宁, 宋雪梅, 牛雨晴, 孙孟艳. 姜黄素抗动脉粥样硬化的作用机制及研究进展[J]. 中医药学报, 2022, 50(7): 116-120. https://doi.org/10.19664/j.cnki.1002-2392.220169
|
[31]
|
Theivanthiran, B., Evans, K.S., DeVito, N.C., et al. (2020) A Tumor-Intrinsic PD-L1/NLRP3 Inflammasome Signaling Pathway Drives Resistance to Anti-PD-1 Immunotherapy. Journal of Clinical Investigation, 130, 2570-2586.
https://doi.org/10.1172/JCI133055
|
[32]
|
王玲, 蒲里津. 内皮细胞氧化应激对动脉粥样硬化发病过程的作用机制[J]. 微循环学杂志, 2022, 32(3): 66-70+78.
|
[33]
|
Liu, X., Weng, X., Xiao, W., Xu, X., Chen, Y. and Chen, P. (2021) Pharmacological and Genetic Inhibition of PD-1 Demonstrate an Important Role of PD-1 in Ischemia-Induced Skeletal Muscle Inflammation, Oxidative Stress, and Angiogenesis. Frontiers in Immunology, 12, Article ID: 586429. https://doi.org/10.3389/fimmu.2021.586429
|
[34]
|
Tkachev, V., et al. (2015) Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism. Journal of Immunology (Baltimore, Md.: 1950), 194, 5789-5800.
|
[35]
|
Jia, L., et al. (2021) Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors Exert Antiapoptosis and Antiinflammatory Activity in Lipopolysaccharide Stimulated Murine Alveolar Macrophages. Experi-mental and Therapeutic Medicine, 21, 400. https://doi.org/10.3892/etm.2021.9831
|